WTAP, transcriptionally regulated by p65, promotes inflammation through m A modification and phase separation

Yong Ge,Rong Chen,Tao Ling,Biaodi Liu,Jingrong Huang,Youxiang Cheng,Yi Lin,Hongxuan Chen,Xiongmei Xie,Guomeng Xia,Guanzheng Luo,Shaochun Yuan,Anlong Xu

DOI: https://doi.org/10.1101/2023.10.30.564747

2024-04-06

Abstract:Emerging evidence has linked dysregulation of -methyladenosine (m A) to inflammation and inflammatory diseases, but the underlying mechanism still needs investigation. Here, we found that high m A modification in a variety of hyperinflammatory states is p65-dependent, because Wilms tumor 1 associated protein (WTAP), a key component of the writer complex, is transcriptionally regulated by p65 and its overexpression can lead to higher m A modification. Mechanistically, upregulated WTAP is more prone to phase separation to facilitate the aggregation of “writer” complex to nuclear speckles and the deposition of m A marks onto transcriptionally active inflammatory transcripts, thereby accelerating proinflammatory response. Furthermore, myeloid deficiency of WTAP attenuates the severity of LPS-induced sepsis and DSS-induced IBD. Thus, the proinflammatory effect of WTAP is a general risk-increasing mechanism, and interrupting the assembly of m A writer complex by targeting the phase separation of WTAP to reduce the global m A level may be a potential and promising therapeutic strategy for alleviating hyperinflammation.

Immunology